Neuroendocrine tumors
Conditions
Interventions
Standard surgical procedure will be performed. During surgery, the near-infrared dye Methylene blue (MB) will be injected and the neuroendocrine tumor will be visualized non-invasively using our exper
Sponsors
Leiden University Medical Center (LUMC)
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with neuroendocrine tumors eligible to undergo a curative resection; 2. Age between 18 and 80 years old.
Exclusion criteria
Exclusion criteria: 1. Patients using SSRI's, SNRI's of TCA's; 2. Allergy to methyleen blue, history of severe renal impairment or G6PD-deficiency; 3. Patient pregnant or lactating.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome parameter is the number of identified neuroendocrine tumors. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secundary parameters are the tumor-to-background ratios measured in patients that recieved MB. | — |
Contacts
Public ContactC.J.H. Velde, van de
Leiden University Medical Center (LUMC), Department of Surgical Oncology, P.O. Box 9600
Outcome results
None listed